Sinldo Information Technology Co., Ltd. based in Beijing, is a leading Hospital Information Technology and mobile healthcare solution provider in China. It covers over 1,000 major public hospitals (400+ Grade A/Class A), 2000 community hospital and medical institutions, with over 600 million patient visits per year.
Sinldo has connected more than 1.5 million doctors and helps to manage 200 million patients each year. The letter of intent outlines the terms of conditions of a commercial agreement and involves the introduction and commercialisation of Algocyte in the regional hospital network in Shanxi province, An Kang city, Han Bin district, in China where there are 3 hospitals in the city, 36 community hospitals and 400 medical units in the surrounding villages which are connected by Sinldo’s digital platform that covers 1,020,000 people.
Signed by Dr Hongqiao Yang Sinldo, Chairman of Sinldo, the letter also establishes a further exploration of a wider adoption of Algocyte in hospital networks across China including 3000 regional hospitals and other medical units.